Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    Sales Team Training Requirements to avoid Off-Label Promotion: Best Practices For Social Media

    View: 227

    Website http://www.onlinecompliancepanel.com/webinar/FDA-SocialMedia-501095/OCT-2015-ES | Want to Edit it Edit Freely

    Category FDA, social media, off-label, Sunshine act, marketing, advertisement, FTC, drugs, medical devices, biologics, Caronia, Amarin

    Deadline: October 14, 2015 | Date: October 15, 2015

    Venue/Country: online Webinar, U.S.A

    Updated: 2015-10-06 14:07:44 (GMT+9)

    Call For Papers - CFP

    Sales Team Training Requirements to avoid Off-Label Promotion: Best Practices For Social Media

    Instructor: Mukesh Kumar

    Product ID: 501095

    Objectives of the Presentation

    Current status of physician perception of off-label and Sunshine Act reporting

    Trends in FDA enforcement regarding off-label promotion

    Impact of Sunshine Act on sales rep entry into clinics

    Best practices for using social media as a communication tool and marketing

    Practical tips for training of sales and marketing teams in social media usage

    Regulatory strategies for creating company policies regarding social media

    Why Should you Attend

    Recently the US courts have made some high-profile decisions regarding FDA’s punitive actions to manufacturers accused of off-label promotion. The Caronia and Amarin cases, have been in much discussion since in that case the court sided with the defendant accused of off-label promotion leading to speculation of its impact on FDA’s enforcement of its rules regarding off-label promotion. The legal discussion apart, these cases have raised new regulatory questions about FDA-acceptable practices for promoting off-label uses for approved products. Also, the Sunshine Act reports created intense media scrutiny of doctor-pharma interactions leading to doctors being increasingly inaccessible to sales reps. These developments have changed how sales force, doctors and other medical professionals interact.

    Who can Benefit

    Marketing and Advertising Professionals

    Pharmaceutical Sales Representatives, Managers, Supervisors and Leaders

    Manufacturers of FDA regulated products: Drug, Medical Device and Biotech Companies, Dietary Supplement Manufacturers

    Legal experts involved in advising manufacturers of marketed products

    Senior management for companies developing new products for US Market

    Regulatory Affairs Professionals, Research Analysts

    For Registration -

    http://www.onlinecompliancepanel.com/webinar/FDA-SocialMedia-501095/OCT-2015-ES

    Note : Use coupon code 1371 and get 10% off on Registration


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.